These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 4253202)

  • 21. Correlation of rhinencephalic electrograms with behavior; a study on humans under the influence of LSD and mescaline.
    MONROE RR; HEATH RG; MICKLE WA; LLEWELLYN RC
    Electroencephalogr Clin Neurophysiol; 1957 Nov; 9(4):623-42. PubMed ID: 13480236
    [No Abstract]   [Full Text] [Related]  

  • 22. Patterns of tolerance to lysergic acid diethylamide and mescaline in rats.
    FREEDMAN DX; AGHAJANIAN GK; ORNITZ EM
    Science; 1958 May; 127(3307):1173-4. PubMed ID: 13555858
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of mescaline and lysergic acid diethylamide on flicker discrimination in the rat.
    Schechter MD; Winter JC
    J Pharmacol Exp Ther; 1971 May; 177(2):461-7. PubMed ID: 5568801
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of lysergic acid diethylamide (LSD) on cortical sensory evoked potentials in the cat.
    LANGFITT TW; FINNEY LA
    Arch Neurol; 1959 Sep; 1():258-68. PubMed ID: 14413973
    [No Abstract]   [Full Text] [Related]  

  • 25. [Behavioral and neurophysiological study of the effect of LSD 25 in the monkey].
    Borenstein P; Chatelier G; Cujo P; Gekière F
    Sem Hop; 1969 Apr; 45(19):1258-70. PubMed ID: 4306998
    [No Abstract]   [Full Text] [Related]  

  • 26. [Sensory isolation].
    Banshchikov VM; Stoliarov GV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1966; 66(9):1428-40. PubMed ID: 4970318
    [No Abstract]   [Full Text] [Related]  

  • 27. Transcallosally evoked potentials and the EEG in the decerebrate dog: actions of tryptaminergic, dopaminergic and adrenergic agonists.
    Pickworth WB; Sharpe LG; Martin WR
    Electroencephalogr Clin Neurophysiol; 1977 Jun; 42(6):809-16. PubMed ID: 67932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spectrum analysis of EEG changes induced by psychotomimetic agents.
    Eidelberg E; Long M; Miller MK
    Int J Neuropharmacol; 1965 Sep; 4(5):255-64. PubMed ID: 5865229
    [No Abstract]   [Full Text] [Related]  

  • 29. A new view of the structural relationship between LSD and mescaline.
    Nichols DE; Pfister WR; Yim GK; Cosgrove RJ
    Brain Res Bull; 1977; 2(3):169-71. PubMed ID: 890502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Critical study on taraxeine].
    Bury JA
    Encephale; 1969; 58(1):69-94. PubMed ID: 4989013
    [No Abstract]   [Full Text] [Related]  

  • 31. Tolerance to a behavioral effect of lysergic acid diethylamide and cross-tolerance to mescaline in the rat: absence of a metabolic component.
    Winter JC
    J Pharmacol Exp Ther; 1971 Sep; 178(3):625-30. PubMed ID: 5571911
    [No Abstract]   [Full Text] [Related]  

  • 32. PSYCHODYNAMIC and therapeutic aspects of mescaline and lysergic acid diethylamide: round table.
    J Nerv Ment Dis; 1957; 125(3):423-4. PubMed ID: 13481746
    [No Abstract]   [Full Text] [Related]  

  • 33. Antidiuresis in man following lysergic acid diethylamide and mescaline.
    Hollister LE; Kanter SL; Dronkert A
    Behav Neuropsychiatry; 1970; 2(3):50-4. PubMed ID: 4913153
    [No Abstract]   [Full Text] [Related]  

  • 34. The amplitude of acoustic evoked potentials and EEG during natural and pharmacologically induced sleep.
    Petrek J; Golda V; Lisonĕk P
    Act Nerv Super (Praha); 1968 May; 10(2):199. PubMed ID: 5728293
    [No Abstract]   [Full Text] [Related]  

  • 35. Reticular multiple unit activity during a progression of states induced by CNS excitants. 3.
    Winters WD; Mori K; Wallach MB; Marcus RJ; Spooner CE
    Electroencephalogr Clin Neurophysiol; 1969 Nov; 27(5):514-22. PubMed ID: 4187037
    [No Abstract]   [Full Text] [Related]  

  • 36. Similarities and differences between mescaline, lysergic acid diethylamide-25 (LSD) and d-amphetamine on various components of fixed interval responding in the rat.
    Tilson HA; Sparber SB
    J Pharmacol Exp Ther; 1973 Feb; 184(2):376-84. PubMed ID: 4688175
    [No Abstract]   [Full Text] [Related]  

  • 37. Studies on the mechanisms of learning. I. Mescaline and the catecholamine hypothesis.
    García Ramos J
    Acta Physiol Lat Am; 1973; 23(2):94-104. PubMed ID: 4747724
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of psychodrugs upon sensory inflow. I. Changes provoked by LSD 25 on the averaged visual evoked responses in man.
    Bachini O; Villar JI; Prieto S; García Austt E
    Acta Neurol Latinoam; 1965; 11(4):383-90. PubMed ID: 5899808
    [No Abstract]   [Full Text] [Related]  

  • 39. The effect of mescaline on the optic evoked potentials in the unanesthetized rabbit.
    SMYTHIES JR; KOELLA WP; LEVY CK
    J Pharmacol Exp Ther; 1960 Aug; 129():462-70. PubMed ID: 13832249
    [No Abstract]   [Full Text] [Related]  

  • 40. Evidence for the action of d-lysergic acid diethylamide, mescaline and bufotenine on 5-hydroxytryptamine receptors in umbilical vasculature.
    Dyer DC
    J Pharmacol Exp Ther; 1974 Feb; 188(2):336-41. PubMed ID: 4359552
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.